Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5
Mariëlle Kloosterman(University Medical Center Groningen), Isabelle C. Van Gelder(University Medical Center Groningen), Luigi Di Biase(Albert Einstein College of Medicine), Jonathan P. Piccini(Clinical Research Institute), Ulrich Schotten(Maastricht University), Paulus Kirchhof(Universität Hamburg), Larissa Fabritz(University of Birmingham), Lluı́s Mont(Hospital Clínic de Barcelona), Hussein R. Al‐Khalidi(Clinical Research Institute), Derick Todd(University of Liverpool), Winnie Chua(University of Birmingham), Jens Cosedis Nielsen(Aarhus University), Karl Georg Häusler(Universität Hamburg)
Cited by 39
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|EP Europace|2016|6.5k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|European Heart Journal|2016|6.4k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k